查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1518752

日本糖尿病市场报告：2024-2032

Japan Diabetes Market Report: 2024-2032
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3个工作天内

价格

2023 年日本糖尿病市场规模达到 54IMARC Group美元。

糖尿病是指人体产生和回应胰岛素激素的能力受损的一种慢性疾病。这导致碳水化合物代谢异常和血液中葡萄糖水平升高。在日本，很大一部分人口年龄超过 60 岁，是第 2 型糖尿病较为流行的年龄。此外，由于日本饮食中含有很大一部分精製碳水化合物，如白米和麵条，这使得人们患糖尿病和加重糖尿病的风险更高。

日本糖尿病市场驱动因素：

随着西方美食影响力的增强、工作时间的增加以及国内农业产量的下降，消费者现在开始依赖加工食品和快餐，如汉堡、玉米捲、热狗和披萨。由于这些食品富含碳水化合物、钠和防腐剂，其消费量的增加导致该国糖尿病病例增加。导致糖尿病病例增加的其他因素包括肥胖人口的增加和久坐的生活方式。然而，为了最大限度地减少该国糖尿病的盛行率，日本政府正在采取多项措施。例如，它透过全民健保系统向在日本居住一年以上的公民和非公民提供健康保险。

本报告回答的关键问题：

  • 到目前为止，日本糖尿病市场的表现如何？
  • COVID-19 对日本糖尿病市场有何影响？
  • 日本糖尿病市场的热门细分市场有哪些？
  • 日本糖尿病市场价值链的各个阶段是什么？
  • 日本糖尿病市场的关键驱动因素和挑战是什么？
  • 日本糖尿病市场的结构如何？
  • 日本糖尿病市场的竞争程度如何？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：糖尿病概述

  • 什么是糖尿病？
  • 糖尿病诊断与治疗
    • 诊断
    • 治疗
  • 糖尿病併发症

第 6 章：日本糖尿病流行病学

  • 糖尿病人口和盛行率
  • 人口和盛行率：按糖尿病类型（1 型和 2 型）
  • 人口和盛行率：按地区
  • 人口及盛行率：依性别分类
  • 人口和盛行率：依年龄组别

第 7 章：日本糖尿病市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测
  • SWOT分析
    • 概述
    • 优势
    • 弱点
    • 机会
    • 威胁
  • 价值链分析
  • 波特五力分析
    • 概述
    • 买家的议价能力
    • 供应商的议价能力
    • 竞争程度
    • 新进入者的威胁
    • 替代品的威胁
  • 市场区隔：按细分市场
    • 日本口服降血糖药市场
      • 历史市场趋势
      • 市场区隔：依类别
      • 关键参与者的市场份额
      • 市场预测
    • 日本胰岛素市场
      • 历史市场趋势
      • 市场区隔：依类别
      • 关键参与者的市场份额
      • 市场预测

第 8 章：竞争格局

  • 市场结构
  • 关键参与者简介
Product Code: SR112024A561

The Japan diabetes market size reached US$ 5.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 7.3 Billion by 2032, exhibiting a growth rate (CAGR) of 3.3% during 2024-2032.

Diabetes refers to a chronic disease in which the ability of a human body to produce and respond to insulin hormone becomes impaired. This results in abnormal metabolism of carbohydrates and elevated levels of glucose in the blood. In Japan, a large section of the population is over 60 years, an age when type-2 diabetes becomes more prevalent. Moreover, as the Japanese diet consists of a significant portion of refined carbohydrates, like white rice and noodles, it puts the population at a higher risk of developing and aggravating diabetes.

Japan Diabetes Market Drivers:

With the growing influence of western cuisines, increasing working hours and declining domestic agricultural production, consumers are now relying on processed food products and fast-food like burger, taco, hotdog and pizza. As these food products are high in carbohydrates, sodium and preservatives, their rising consumption has increased the cases of diabetes in the country. The other factors that are contributing to the increasing cases of diabetes include growing obese population and sedentary lifestyles. However, to minimize the prevalence of diabetes in the country, the Government of Japan is undertaking several initiatives. For instance, it is offering health insurance to both the citizens and non-citizens residing for more than a year in Japan through their universal health care system.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the Japan diabetes market report, along with forecasts for the period 2024-2032. Our report has categorized the market based on segment.

Breakup by Segment:

Oral Antidiabetics

Insulin

Currently, insulin represents the dominant segment, accounting for the majority of the total market share. Insulin in Japan is usually taken through pens, pumps, syringes and jet injectors as they offer convenience to the patients. Increasing diagnostic rates and awareness among patients are enabling them to incorporate insulin therapy for treating diabetes.

Competitive Landscape:

The competitive landscape of the market has been analyzed in the report with detailed profiles of key players operative in the industry.

Key Questions Answered in This Report:

  • How has the Japan diabetes market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan diabetes market?
  • Which are the popular segments in the Japan diabetes market?
  • What are the various stages in the value chain of the Japan diabetes market?
  • What are the key driving factors and challenges in the Japan diabetes market?
  • What is the structure of the Japan diabetes market and who are the key players?
  • What is the degree of competition in the Japan diabetes market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Diabetes Disease Overview

  • 5.1 What is Diabetes?
  • 5.2 Diabetes Diagnosis and Treatment
    • 5.2.1 Diagnosis
    • 5.2.2 Treatment
  • 5.3 Diabetes Complications

6 Japan Diabetes Epidemiology

  • 6.1 Diabetes Population and Prevalence Rates
  • 6.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
  • 6.3 Population and Prevalence Rates by Region
  • 6.4 Population and Prevalence Rates by Gender
  • 6.5 Population and Prevalence Rates by Age Group

7 Japan Diabetes Market

  • 7.1 Market Overview
  • 7.2 Market Performance
  • 7.3 Impact of COVID-19
  • 7.4 Market Forecast
  • 7.5 SWOT Analysis
    • 7.5.1 Overview
    • 7.5.2 Strengths
    • 7.5.3 Weaknesses
    • 7.5.4 Opportunities
    • 7.5.5 Threats
  • 7.6 Value Chain Analysis
  • 7.7 Porter's Five Forces Analysis
    • 7.7.1 Overview
    • 7.7.2 Bargaining Power of Buyers
    • 7.7.3 Bargaining Power of Suppliers
    • 7.7.4 Degree of Competition
    • 7.7.5 Threat of New Entrants
    • 7.7.6 Threat of Substitutes
  • 7.8 Market Breakup by Segment
    • 7.8.1 Japan Oral Antidiabetics Market
      • 7.8.1.1 Historical Market Trends
      • 7.8.1.2 Market Breakup by Class
      • 7.8.1.3 Market Shares of Key Players
      • 7.8.1.4 Market Forecast
    • 7.8.2 Japan Insulin Market
      • 7.8.2.1 Historical Market Trends
      • 7.8.2.2 Market Breakup by Class
      • 7.8.2.3 Market Shares of Key Players
      • 7.8.2.4 Market Forecast

8 Competitive Landscape

  • 8.1 Market Structure
  • 8.2 Profiles of Key Players

List of Figures

  • Figure 1: The Impact of Diabetes in the Human Body
  • Figure 2: Diabetes Complications
  • Figure 3: Global: Breakup of Diabetes Patients by Region, (in %) 2023 & 2032
  • Figure 4: Body Mass Index and Relative risk of Type-2 Diabetes
  • Figure 5: Japan: Total Number of Diabetes Patients (in 000), 2018-2023
  • Figure 6: Japan: Total Number of Diabetes Patients Forecast (in 000), 2024-2032
  • Figure 7: Japan (Type1 & Type2): Total Number of Diabetes Patients (in 000), 2018-2023
  • Figure 8: Japan (Type1 & Type2): Total Number of Diabetes Patients Forecast (in 000), 2024-2032
  • Figure 9: Japan (Urban & Rural): Total Number of Diabetes Patients (in 000), 2018-2023
  • Figure 10: Japan (Urban & Rural): Total Number of Diabetes Patients Forecast (in 000), 2024-2032
  • Figure 11: Japan (Male & Female): Total Number of Diabetes Patients (in 000), 2018-2023
  • Figure 12: Japan (Male & Female): Total Number of Diabetes Patients Forecast (in 000), 2024-2032
  • Figure 13: Japan: Total Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (in 000), 2018-2023
  • Figure 14: Japan: Total Number of Diabetes Patients Forecast by Age Group (20-39), (40-59) & (60-79) (in 000), 2024-2032
  • Figure 15: Japan: Diabetes Drug Industry Overview
  • Figure 16: Japan: Diabetes Drug Market: Sales Value (in Billion US$), 2018-2023
  • Figure 17: Japan: Diabetes Drug Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 18: Japan: Diabetes Drug Market: SWOT Analysis
  • Figure 19: Japan: Diabetes Drug Market: Value Chain Analysis
  • Figure 20: Japan: Diabetes Drug Market: Porters Five Forces Analysis
  • Figure 21: Japan: Diabetes Drug Market: Breakup of Insulin and Oral Antidiabetics (in %), 2018-2023
  • Figure 22: Japan: Diabetes Drug Market Forecast: Breakup of Insulin and Oral Antidiabetics (in %), 2024-2032
  • Figure 23: Japan: Oral Antidiabetics Market: Sales Value (in Million US$), 2018-2023
  • Figure 24: Japan: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2018 & 2023
  • Figure 25: Japan: Oral Anti-diabetics Market: Sales Share of Key Players (in %)
  • Figure 26: Japan: Oral Antidiabetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Japan: Insulin Market: Sales Value (in Million US$), 2018-2023
  • Figure 28: Japan: Breakup of Insulin Market by Class (in %), 2023
  • Figure 29: Japan: Insulin Market: Sales Share of Key Players (in %)
  • Figure 30: Japan: Insulin Market Forecast: Sales Value (in Million US$), 2024-2032

List of Tables

  • Table 1: Diagnosis of Diabetes
  • Table 2: Global: Diabetes Population Breakup by Country (in 000's), 2023 and 2032
  • Table 3: Japan: Total Prevalence & Number of Diabetes Patients, 2018, 2023 & 2032
  • Table 4: Japan (Type1 & Type2): Total Prevalence & Number of Diabetes Patients, 2018, 2023 & 2032
  • Table 5: Japan (Urban & Rural): Total Prevalence & Number of Diabetes Patients, 2018, 2023 & 2032
  • Table 6: Japan (Male & Female): Total Prevalence & Number of Diabetes Patients, 2018, 2023 & 2032
  • Table 7: Japan: Total Prevalence & Number of Diabetes Patients by Age Group (20-39, 40-59, 60-79 - In Millions), 2018, 2023 & 2032
  • Table 8: Japan: Diabetes Drug Market: Competitive Structure